High Resolution Image Download MS PowerPoint Slide Fourteen new 2,3-dialkoxyphenazine derivatives with two different alkoxy groups bearing R 1 and R 2 alkyl chains, defined as −CH 2 CH(CH 3 ) 2 and −(CH 2 ) n −1 CH 3 for n = 1, 2, 4, 6, 8, and 10, were prepared via regioselective synthesis. The applied synthetic protocol is based on the following reactions: the Buchwald–Hartwig coupling of a nonsymmetrically substituted 4,5-dialkoxy-2-nitroaniline with a 1-bromo-2-nitrobenzene derivative featuring additional tert -butyl, trifluoromethyl or two methoxy groups; the reduction of bis(2-nitrophenyl)amine; and a final step of tandem-like oxidation that leads to the preparation of a heterocyclic phenazine system. The regioselectivity of these steps and the molecular structure of the compounds under investigation were confirmed by nuclear magnetic resonance and additionally by single-crystal X-ray diffraction performed for some examples of 5 and 6 phenazine series. For 7-( tert -butyl)-3-isobutoxy-2-(octyloxy)phenazine ( 5f ), 3-(hexyloxy)-2-isobutoxy-7-(trifluoromethyl)phenazine ( 6e ), and 2,3-bis(hexyloxy)-7,8-dimethoxyphenazine ( 7 ), viability and cytotoxicity assays were performed on the LoVo human colon adenocarcinoma cell line, with 5f confirmed to exhibit cytotoxicity.
No takes yet. Share an insight, caveat, or question.
Ręka et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: